In the first quarter of 2026, Mirion Technologies maintained steady operational momentum, leveraging recent acquisitions to broaden its product portfolio and deepen U.S. nuclear market penetration. The company’s dual-segment business model — Nuclear & Safety and Medical — benefits from entrenched regulatory barriers and strong customer relationships across global nuclear facilities and cancer centers. Strategic focus on emerging markets such as small modular reactors (SMRs) and software-driven radiation safety platforms positions Mirion for structural growth. However, ongoing geopolitical tensions and global trade uncertainties present notable headwinds for the supply chain and market access.